Medical Affairs Manager

in health

What a Medical Affairs Manager really does across UK pharma biotech and medical devices plus the skills pathways and honest salary bands by level.

9 min read


A Medical Affairs Manager is accountable for the clinical and scientific integrity of how a health product is understood, used, and trusted. That applies inside the company, where commercial and product teams want clear answers, and outside it, with the clinicians, pharmacists, and health system stakeholders who decide whether a product belongs in real care. The role sits at the meeting point of evidence, compliance, and the way care is actually delivered. It exists to translate medical reality into decisions the business can stand behind without overreaching.

Most Medical Affairs Managers work in pharmaceutical and biotech companies, medical device and diagnostics makers, contract research organisations (CROs), consumer health businesses, and digital health scale-ups. The common thread is that the product can influence diagnosis, treatment choices, or patient outcomes, so what the company says, teaches, and implies has to be medically sound and appropriately evidenced. In the UK that means working within the boundaries set by the MHRA, the ABPI Code of Practice for prescription medicines, and the conduct expected of anyone who holds a clinical registration with the GMC, NMC, GPhC, or HCPC.

The job is built on ownership. A Medical Affairs Manager owns the medical narrative, the medical risk posture, and the quality of scientific exchange with external experts. Literature reviews, evidence plans, advisory boards, and materials review are the tools they use to hold that line.

How this role differs in health and life sciences

In many industries you can iterate messaging quickly and adjust with little external consequence. In health and life sciences the same instinct collides with patient safety, sensitive data, and strict controls on what may be said or shown. A claim that runs ahead of the evidence is not just a marketing risk. It can mislead a prescriber and reach a patient.

A Medical Affairs Manager operates where outcomes are consequential and adoption depends on clinical credibility as much as usefulness. The texture of the work shifts with the setting. In pharma and biotech the ABPI Code governs almost every external communication, and medical sign-off on promotional material is a formal step, not a courtesy. In medical devices and diagnostics the gravity sits around the intended use defined under UK and EU regulation and the boundaries of what the evidence supports. In a CRO the focus leans toward study conduct and Good Clinical Practice (GCP). In digital health, where a product may not be a medicine but still lands in a clinical pathway, the discipline is the same even when the regulatory category is lighter.

Across all of them, Medical Affairs is usually the function closest to the question every serious buyer eventually asks: why should anyone trust this? Turning product ambition into defensible clinical positioning, without inflating it, is the job.

Core responsibilities in health and life sciences

Day to day, the Medical Affairs Manager makes calls that shape what the organisation can responsibly promise and what it must hold back. The pattern of the work looks like this.

  • Interpret the evidence base with product, regulatory, and commercial teams, and be clear about where the data is strong, where it is emerging, and where a claim cannot yet be supported.
  • Review medical and promotional content for accuracy and balance, and apply the relevant code (the ABPI Code in prescription medicines) before anything goes external.
  • Engage clinicians, pharmacists, and subject matter experts in genuine scientific exchange through advisory boards, medical education, and field medical work, then feed that insight back into product and evidence decisions.
  • Build and steer the evidence plan: identify gaps, scope real-world evidence or post-market studies, and prioritise the work that most affects credibility and patient safety.
  • Act as the medical governance checkpoint, deciding what can be said, taught, and implied, and when something needs to escalate.
  • Handle medical information and safety signals appropriately, routing adverse events and product queries to the right function rather than answering off the cuff.
  • Hold the line on trade-offs: support speed to launch but not at the cost of scientific credibility, and back broader adoption only where the product is appropriate and the risk is understood.

When commercial teams push for a sharper claim, Medical Affairs is the counterweight that decides what can be supported, what must be qualified, and what needs new evidence before it becomes part of the story.

Skills and competencies for health and life sciences

Core skillWhat it looks like in this sectorWhy it matters
Clinical and scientific judgementReading a trial or real-world dataset and knowing what is clinically meaningful, not just statistically presentKeeps product claims aligned with how clinicians actually weigh safety, relevance, and utility
Evidence interpretationComfort with imperfect heterogeneous evidence from RCTs, registries, real-world data, and usability studiesSupports credible positioning without overstating certainty, which protects trust and lowers clinical risk
Regulatory and code fluencyWorking knowledge of the ABPI Code, MHRA expectations, GCP, and device or diagnostics intended-use rulesPrevents non-compliant claims and the reputational and legal fallout that follows them
Stakeholder credibilityEngaging clinicians and experts in real scientific exchange rather than sellingDrives adoption through trust and surfaces risks early through honest external feedback
Governance and boundary-settingClear decisions on what may be said, taught, and implied, and when to escalateReduces inappropriate claims, inconsistent messaging, and downstream compliance issues
Cross-functional leadershipAligning product, commercial, regulatory, market access, and clinical voices on one defensible planAvoids fragmented narratives and keeps the organisation consistent under sector constraints

Salary ranges in UK health and life sciences

Medical Affairs pay tracks the medical accountability the role carries: how close the product sits to clinical decisions, how serious the consequence of misuse is, and how much governance authority the person owns. Scope matters too (one product versus a portfolio, a UK remit versus international, and whether the role manages people). Setting shifts the picture as well. Large pharma and biotech tend to pay more than consumer health or early-stage digital health, and London and the South East carry a clear premium. Most roles add a bonus, commonly around 10 to 15 per cent of base, with equity more common in venture-backed companies than in established employers.

Experience levelEstimated annual salary rangeWhat drives compensation
Junior (Medical Advisor or Associate)London & South East: £45,000–£58,000. Rest of UK: £40,000–£52,000Scoped to execution with close supervision; pay moves with scientific writing, evidence handling, and degree of external contact
Mid-level (Medical Affairs Manager)London & South East: £65,000–£90,000. Rest of UK: £58,000–£80,000Ownership of a therapy area or product, independent materials review, and growing responsibility for evidence and stakeholders
SeniorLondon & South East: £90,000–£115,000. Rest of UK: £80,000–£105,000Higher accountability for medical strategy, escalation ownership, influence over claims and roadmap, and a senior external footprint
Lead (Senior Manager)London & South East: £110,000–£140,000. Rest of UK: £100,000–£128,000Portfolio ownership, cross-functional leadership, governance authority, and management of medical risk across workstreams
Head or DirectorLondon & South East: £140,000–£200,000. Rest of UK: £125,000–£175,000Organisational accountability for the medical governance model, team leadership, executive influence, and reputation across product lines

Sources: Glassdoor UK (Medical Affairs Manager average base around £69,000 with total pay near £83,000 and London submissions reaching £115,000 to £123,000), Michael Page and PageGroup life sciences salary guidance (Medical Affairs Manager to Director banding), the CK Group medical affairs salary survey (bonus norms of 10 to 15 per cent), plus Reed and Indeed UK live postings. Treat these as a guide; real offers move with employer, setting and specialism.

Beyond base, a formal on-call allowance is not standard in Medical Affairs, but some roles expect responsiveness during launches, safety incidents, or urgent external requests. Where that expectation is explicit and frequent, clarify whether the package reflects it. Total pay varies most with product risk, governance authority, leadership scope, and whether the role supports multiple markets or high-stakes launches.

Career pathways

Entry points usually run through a clinical or scientific background: pharmacists, doctors, nurses, and life scientists moving into industry, or people arriving from clinical research, medical writing, medical information, or real-world evidence work. People also cross in from digital health implementation, clinical consulting, or health economics, especially if they have worked close to clinical decisions and can translate between clinical and product worlds. A life sciences degree is common, and a higher degree (MSc, PhD, PharmD) or a clinical registration strengthens credibility, though neither is universally required.

Progression is best read as expanding ownership. Early on the focus is accurate execution: contributing to materials, supporting evidence synthesis, and learning governance expectations. With experience the role turns strategic, owning medical positioning, shaping evidence plans, and acting as the decisive gatekeeper for claims and education. Lead and Head or Director paths widen scope across products and geographies, formalise the governance model, and shift toward organisational risk leadership and external credibility at scale. Adjacent moves into market access, medical strategy, or regulatory affairs are common at the senior end.

FAQ

Do I need to be a doctor to become a Medical Affairs Manager?

Not always. Many roles value a clinical registration, and some senior medical posts require a medical degree, but plenty prioritise deep therapeutic knowledge, evidence interpretation, and credible engagement with clinicians. What matters most is whether you can take accountable medical decisions and defend them with appropriate evidence and judgement. Pharmacists and PhD scientists are well represented in the function.

How is my performance evaluated if I am not in a sales role?

You are usually assessed on the quality of medical governance and the impact of your medical strategy: clarity and consistency of claims, the strength of evidence plans, stakeholder feedback, and how effectively you reduce medical risk while enabling responsible growth. Strong performance looks like fewer late-stage escalations, higher trust from clinical stakeholders, and fewer avoidable compliance issues.

How does this differ from Regulatory Affairs or Market Access?

Regulatory Affairs owns the formal submissions and approvals with bodies such as the MHRA. Market Access builds the value and reimbursement case, often with NICE in mind. Medical Affairs owns the scientific exchange, the evidence narrative, and the medical sign-off that keeps communication accurate and compliant. The three work closely and people move between them, but the accountabilities are distinct.

Find your next role

Ready to take ownership of medical credibility across pharma biotech devices or digital health? Search Medical Affairs Manager roles on Meeveem and compare scope, risk level, and growth pathways.